Venture-Backed Startups

0 investors

Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.

1 investor

BioCatch develops behavioral biometric authentication technology for fraud detection and identity verification.

8 investors

0 investors

BioCell Analytica provides effect-based analysis using cultured cells to detect health- and environment-hazardous contaminants in water, soil, and sediment, capturing the combined "cocktail effect" of multiple substances. It serves the water industry for testing drinking water, wastewater treatment efficiency, and chemical pollution monitoring.

1 investor

0 investors

0 investors

Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.

2 investors

Bioceres Crops develops and commercializes agricultural productivity solutions—including patented seed technologies (such as its HB4 drought-tolerant program), microbial ag-inputs, crop nutrition and protection products, and digital tools for growers. It serves farmers and agricultural stakeholders with technologies aimed at improving crop resilience to climate change and enabling production traceability.

1 investor

0 investors

BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.

1 investor

Biochar Now manufactures biochar at large scale using kiln-based slow pyrolysis technology, serving applications such as specialty agriculture, land reclamation, oil and gas, odor control, bio-filler, and nutrient removal. The company operates in the biochar and carbon materials industry.

0 investors

BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods. The company conducts comprehensive biomarker assays and works with clinicians and researchers.

1 investor

1 investor

1 investor

BioClé is a biotechnology company developing a delivery platform based on bacterial extracellular vesicles (bEVs) to improve the stability, bioavailability, and cellular uptake of bioactive compounds.

1 investor

0 investors

BioClinique operates a network of medical laboratories providing clinical testing services across the Île-de-France region in France.

1 investor

3 investors

BioCollabs sells plant-based dietary supplements built around clinically-backed, trademarked phytosome ingredients aimed at supporting liver health, digestion, metabolism, and detoxification. Its formulations are marketed to consumers with concerns such as belly fat, fatty liver, cholesterol, and bloating.

3 investors

The BioCollective develops microbiome research tools, including a whole-stool BioCollector Kit, a fecal sample bank, and the Bioflux computational metabolic model used to build and evaluate probiotic consortia. Its products and reference materials serve research institutions, biotherapeutics companies, and probiotic developers, and it also produces the BiotiQuest consumer probiotic brand.

0 investors

BioCompute is developing DNA-based data storage technology, offering exclusive pilot programs for early access. The company operates in the data storage and biotechnology space.

1 investor

Endobits is clinical decision-support software that runs on top of FDA-cleared continuous glucose monitors to help qualified healthcare professionals and clinics manage glucose-related conditions such as dysglycemia and pre-diabetes. The software supports clinician-directed care and references CPT codes for billing, while providers retain full clinical authority.

1 investor

BioConsortia develops microbial products for agriculture, including nitrogen-fixation, biocontrol, and biostimulant solutions for crops. The company uses proprietary microbial discovery and optimization tools to build its product portfolio.

0 investors